SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group (NBIS) is trending as a critical local council vote unfolds on a massive AI data center project in Independence, Missouri, igniting intense community debate over its substantial economic prospects versus local concerns, while market sentiment also contends with broader sector volatility and geopolitical tensions impacting AI infrastructure plays.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd is trending with high volume and price appreciation due to escalating Middle East tensions, including threats to the Strait of Hormuz and attacks on regional energy infrastructure, leading the community to speculate on its continued upside compared to other oil plays.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is surging amid institutional investment, notably a hedge fund stake, and growing recognition from partners like Quantum Computing and Sivers, fueling community excitement over its disruptive optical interconnect technology crucial for scaling AI infrastructure and a forecasted strong revenue ramp.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil (BATL) is seeing extreme trading volume and a rapid price increase, driven by escalating geopolitical tensions in the Middle East that are propelling oil prices higher. The community is buzzing about a potential short squeeze, fueled by reports of high borrowing costs and a scarcity of shares available for shorting.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in November 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB is trending after its recent earnings report, which, despite strong performance, included weaker-than-expected forward guidance and leadership changes, triggering a sharp stock decline. The community is split between those who view the pullback as an overblown reaction and a buying opportunity, and others who believe the valuation adjustment is justified.

AeroVironment, Inc. engages in the design, development, and production of multi-domain robotic systems and related services for government agencies and businesses. It operates through the following business segments: UnCrewed Systems, Loitering Munitions Systems, and MacCready Work. The UnCrewed Systems segment focuses primarily on small UAS products designed to operate reliably at lower altitudes in a wide range of environmental conditions. The Loitering Munitions Systems segment focuses primarily on tube-launched aircraft that deploy with the push of a button, fly at higher speeds than small UAS products, and perform either effects delivery or reconnaissance missions, and related support services including training, spare parts, product repair, and product replacement. The MacCready Works segment focuses on customer-funded research and development in the areas of HAPS, robotics, sensors, software analytics, data intelligence, and connectivity. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment Inc. (AVAV) is sharply lower after a Raymond James downgrade, citing recompetition for a key Space Force contract, triggered a massive intraday sell-off and intensified community debate over market manipulation.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group Inc. is trending after announcing record annual revenue for 2025 and a major profitability turnaround, alongside a significant AI infrastructure pipeline and a recent MoU in Saudi Arabia. The community is actively debating whether these strong fundamentals position the deeply undervalued stock for a re-rating or if past skepticism and ongoing short interest will continue to weigh on its price.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending following a recent strategic collaboration aimed at deploying significant fuel cell power for rapidly expanding AI data centers, positioning its molten carbonate technology as a key solution for critical energy demands. While optimism builds around its potential to secure substantial contracts in this booming sector, the community remains divided, with some drawing comparisons to successful peers and others expressing skepticism given the company's past performance and ongoing share dilution.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is trending due to Nvidia's significant investment and strategic partnership to advance optical interconnects for AI data centers, driving community excitement around photonics as the new AI infrastructure frontier, despite some debates over its rapid valuation.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is trending after the FDA stated its gene therapy for Huntington's disease, AMT-130, lacks sufficient data for a BLA and is recommending a sham surgery-controlled study. This decision has sparked community debate over the agency's strict stance and potential delays for a critical treatment, with many criticizing the ethical implications of a sham trial for such a debilitating condition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

iSpecimen Inc (ISPC) Stock Surged 42% After-Hours: Here's The News Behind The Move

iSpecimen shares jumped 42.4% after hours following a $5.5 million private placement, though the stock remains near its 52-week low.read more...

<ul class="summary-bullets"><li>The after-hours move followed a newly announced private placement that provides near-term funding visibility.</li><li>The financing terms outline convertible preferred shares tied to future common stock pricing.</li><li>The announcement came after a prolonged decline that had taken the stock to its lowest recorded level.</li></ul><p>Shares of iSpecimen Inc. (ISPC) jumped about 60% in after-hours trading on Tuesday, rebounding from a record low after the company announced a $5.5 million private placement that appeared to ease near-term liquidity concerns.</p><h2 class="st-heading-2"><strong>Capital Raise Sparks Relief Rally</strong></h2><p>The company said it entered into a securities purchase agreement with accredited investors for gross proceeds of nearly $5.5 million, before fees. The financing involves the issuance of 6,875 shares of newly designated Series C Convertible Preferred Stock priced at $800 per share.</p><p>Each preferred share has a stated value of $1,000 and can be converted into common stock at a price equal to 85% of the prior day’s closing price. iSpecimen said the funds will go toward marketing, working capital, and other general corporate needs, with the transaction expected to close around Dec. 31.</p><h2 class="st-heading-2"><strong>What Went Wrong Before The Bounce</strong></h2><p>According to the company’s SEC filings, iSpecimen has reported recurring operating losses over multiple years, generated limited revenue relative to expenses, and financed operations through multiple equity and convertible security offerings.</p><p>iSpecimen has yet to achieve sustained profitability from its biospecimen marketplace, with operating expenses consistently exceeding revenue. The company has also repeatedly disclosed the need for additional capital to continue operations, pointing to pressures that weighed on the stock and pushed shares to a record low.</p><h2 class="st-heading-2"><strong>Crypto Strategy Adds Volatility&nbsp;</strong></h2><p>Investor uncertainty was amplified earlier this year after iSpecimen announced plans to pursue a corporate treasury strategy tied to the Solana blockchain ecosystem.&nbsp;</p><p>In August, the company said it was exploring the creation of an up to $200 million digital asset treasury centered on Solana, later disclosing that it had been approached by cryptocurrency-related firms regarding tokenized assets and treasury opportunities.</p><p>The company said the proposed digital asset treasury would be funded primarily through capital that may be raised from time to time, according to its August and September disclosures.</p><h2 class="st-heading-2"><strong>How Did Stocktwits Users React?</strong></h2><p>On Stocktwits, retail sentiment for iSpecimen was ‘extremely bullish’ amid ‘extremely high’ message volume.</p><figure class="image"><img style="aspect-ratio:968/141;" src="https://news.stocktwits-cdn.com/ispc_ss_png_47d45605c0.webp" alt="ispc ss.png" width="968" height="141"><figcaption>ISPC sentiment and message volume as of December 30| Source: Stocktwits</figcaption></figure><p><a href="https://stocktwits.com/symbol/ISPC">iSpecimen’s stock</a> has declined 89% so far in 2025.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

iSpecimen’s stock (ISPC) has declined 89% so far in 2025. (Representative Image: Getty Images)

iSpecimen Stock Surges 60% After Hours Off A Record Low — What Triggered The Turn?

Shares rebounded sharply after the company disclosed fresh capital-raising plans following a steep selloff.

Equity

iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.

iSpecimen Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $MDB earnings today?

Current Price	$0.2601
Prev Close	$0.25
Open	$0.25
Dividend Yield	0.00%
50-Day Moving Average	$0.3303
Beta	0.75
Avg. Volume	841,912.60
PE Ratio	-0.03

52-Week High	$3.18
52-Week Low	$0.2302
Market Capitalization	$2.44M
EPS (Annual)	-$17.58
Price to Book	0.80
Revenue Per Employee	$387,129.79

ISPC
iSpecimen Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ISPC News

ISPCiSpecimen Inc